These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 16425186)
1. Lymphocytapheresis in the treatment of psoriasis vulgaris. Liumbruno GM; Centoni PE; Molfettini P; Ceretelli S; Ceccarini M; Bachini L; Pomponi A; Bagnoni G; Vitolo M; Eberle O; Biondi A; Sodini ML J Clin Apher; 2006 Oct; 21(3):158-64. PubMed ID: 16425186 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis. Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T Ther Apher Dial; 2008 Feb; 12(1):13-8. PubMed ID: 18257807 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study. Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064 [TBL] [Abstract][Full Text] [Related]
4. Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis. Shukuya R; Hasegawa T; Niwa Y; Okuma K; Ikeda S J Dermatol; 2011 Dec; 38(12):1130-4. PubMed ID: 22007872 [TBL] [Abstract][Full Text] [Related]
5. Generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis. Fujisawa T; Murase K; Okumura Y; Kanoh H; Doi T; Yoshida S; Ogura S; Seishima M Ther Apher Dial; 2011 Aug; 15(4):374-8. PubMed ID: 21884472 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of three cases of generalized pustular psoriasis with granulocyte and monocyte adsorption apheresis. Suzuki A; Haruna K; Mizuno Y; Kuwae Y; Ono Y; Okumura K; Negi O; Kon Y; Takeuchi K; Takamori K; Ikeda S; Suga Y Ther Apher Dial; 2012 Oct; 16(5):445-8. PubMed ID: 23046369 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study. Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949 [TBL] [Abstract][Full Text] [Related]
8. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. Kircik L; Bagel J; Korman N; Menter A; Elmets CA; Koo J; Yang YC; Chiou CF; Dann F; Stevens SR; J Drugs Dermatol; 2008 Mar; 7(3):245-53. PubMed ID: 18380206 [TBL] [Abstract][Full Text] [Related]
9. Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. Schäfer I; Hacker J; Rustenbach SJ; Radtke M; Franzke N; Augustin M Eur J Dermatol; 2010; 20(1):62-7. PubMed ID: 19822480 [TBL] [Abstract][Full Text] [Related]
10. Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis. Kanekura T; Yoshii N; Yonezawa T; Kawabata H; Saruwatari H; Kanzaki T J Am Acad Dermatol; 2003 Aug; 49(2):329-32. PubMed ID: 12894091 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study. Mazzotta A; Esposito M; Costanzo A; Chimenti S Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of climatotherapy at the Dead Sea for psoriasis vulgaris: A community-oriented study introducing the 'Beer Sheva Psoriasis Severity Score'. Cohen AD; Van-Dijk D; Naggan L; Vardy DA J Dermatolog Treat; 2005; 16(5-6):308-13. PubMed ID: 16428150 [TBL] [Abstract][Full Text] [Related]
13. Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives. Vernia P; D'Ovidio V; Meo D Transfus Apher Sci; 2010 Oct; 43(2):227-9. PubMed ID: 20817610 [TBL] [Abstract][Full Text] [Related]
14. [Clinical experience with etanercept in the treatment of psoriasis]. Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167 [TBL] [Abstract][Full Text] [Related]
15. Initial experience with routine administration of etanercept in psoriasis. de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432 [TBL] [Abstract][Full Text] [Related]
16. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis. D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521 [TBL] [Abstract][Full Text] [Related]
17. Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy. Sakanoue M; Takeda K; Kawai K; Kanekura T Ther Apher Dial; 2013 Oct; 17(5):477-83. PubMed ID: 24107275 [TBL] [Abstract][Full Text] [Related]
18. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study. Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769 [TBL] [Abstract][Full Text] [Related]
19. Quo vadis haemapheresis. Current developments in haemapheresis. Borberg H Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691 [TBL] [Abstract][Full Text] [Related]
20. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients. Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]